EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences

Rhea-AI Summary

EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT) announced its senior management will present at four upcoming conferences. The presentations include:

• Ophthalmology Futures Euro Forums 2021 on September 8, 2021, featuring Jay Duker, M.D.
• H.C. Wainwright 23rd Annual Global Investor Conference on September 13, 2021.
• Cantor Fitzgerald Virtual Global Healthcare Conference on September 29, 2021.
• Benzinga Healthcare Small Cap Conference on September 30, 2021.

Recordings and webcasts will be available on their website.

WATERTOWN, Mass, Sept. 07, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced that EyePoint Pharmaceuticals’ senior management team will present at the following four upcoming conferences:

• Ophthalmology Futures Euro Forums 2021 Virtual Retina Forum
  Forum: Corporate Presentation and Panel featuring Jay Duker, M.D., Chief Strategic Scientific Officer of EyePoint Pharmaceuticals
  Date: Wednesday, September 8, 2021
  Time: 7:50AM-3:30PM Eastern Time

• H.C. Wainwright 23^rd Annual Global Investor Conference
  Forum: Corporate Presentation
  Date: Monday, September 13, 2021
  Time: 7:00AM Eastern Time

• Cantor Fitzgerald Virtual Global Healthcare Conference
  Forum: Corporate Presentation
  Date: Wednesday, September 29, 2021
  Time: 8:40-9:10 AM Eastern Time

• Benzinga Healthcare Small Cap Conference
  Forum: Corporate Presentation
  Date: Thursday, September 30, 2021
  Time: 11:55AM-12:15PM Eastern Time

The H.C. Wainwright 23rd Annual Global Investor Conference, Cantor Fitzgerald Virtual Global Healthcare Conference and Benzinga Healthcare Small Cap Conference presentations will be recorded, and a webcast and subsequent archived replay of each recorded corporate presentation may be accessed via the Investors section of the Company website at www.eyepointpharma.com.

About EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing innovative therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert^® technology for sustained intraocular drug delivery including EYP-1901, a potential twice-yearly sustained delivery intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. The Company has two commercial products: YUTIQ^®, for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, and DEXYCU^®, for the treatment of postoperative inflammation following ocular surgery. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts. To learn more about the Company, please visit www.eyepointpharma.com and connect on Twitter and LinkedIn.

Investors:

Christina Tartaglia
Stern IR
Direct: 212-698-8700
christina.tartaglia@sternir.com

Media Contact

Amy Phillips
Green Room Communications
Direct: 412-327-9499
aphillips@greenroompr.com

FAQ

What conferences will EyePoint Pharmaceuticals (EYPT) present at in September 2021?

EyePoint Pharmaceuticals will present at the Ophthalmology Futures Euro Forums on September 8, H.C. Wainwright 23rd Annual Global Investor Conference on September 13, Cantor Fitzgerald Virtual Global Healthcare Conference on September 29, and Benzinga Healthcare Small Cap Conference on September 30, 2021.

When is the H.C. Wainwright Conference for EyePoint Pharmaceuticals (EYPT)?

The H.C. Wainwright 23rd Annual Global Investor Conference for EyePoint Pharmaceuticals is scheduled for September 13, 2021, at 7:00 AM Eastern Time.

What are the presentation times for EyePoint Pharmaceuticals (EYPT) at the upcoming conferences?

EyePoint Pharmaceuticals will present at 7:50 AM to 3:30 PM on September 8, 2021, 7:00 AM on September 13, 2021, 8:40-9:10 AM on September 29, 2021, and 11:55 AM-12:15 PM on September 30, 2021.

Where can I find the webcasts of EyePoint Pharmaceuticals (EYPT) presentations?

Webcasts and archived replays of EyePoint Pharmaceuticals' presentations can be accessed via the Investors section of their website.

What is EyePoint Pharmaceuticals (EYPT) known for?

EyePoint Pharmaceuticals focuses on developing therapeutics for serious eye disorders, leveraging proprietary technology for sustained intraocular drug delivery.